@col75 This is a great post Col. I would simply add (possibly not the right thread), that with an Oncarlytics FDA IND around the corner (possibly days away), with the Professor Kaumaya PD1 Vaxx blockbuster set to be dosed into the first patient (in combo with Roche) and with interim data from the Hervaxx/Keytruda NEW HERIZON combo on the horizon this financial year, IMU may well be launching space rockets again..
